Join us on June 5, 2024, at 1 PM (ET) for a webinar on tackling the reproducibility and generalizability challenges in #MachineLearning ! Learn strategies for data accessibility, leakage prevention, preprocessing, algorithm selection, and more to ensure reliable ML outcomes. 📊

#HRS2024 Great presentation by Zahra Azizi, MD, MSc on “How Will ChatGPT and Generative Al Change Heart Rhythm Cardiology?” Addressing biases in #Al algorithms is vital to ensure equitable performance in healthcare Heart Rhythm Society Stanford Medicine Stanford Center for Digital Health Stanford Department of Medicine Ottawa IM

Our recent paper "Clinical Text Datasets for Medical Artificial Intelligence and Large Language Models — A Systematic Review" has been published in NEJM AI ! The lack of clinical text data is a long-term challenge/pain for #AIinMedicine and clinical LLM researchers. After

Join next week's #AI Webinar on Confronting the Reproducibility Crisis in Machine Learning! Learn effective strategies to address challenges in enhancing the reproducibility & generalizability of #ML projects! Jun 5 | 1:00 PM ET | Earn 1 HR #SIIM IIP CE ecs.page.link/BvZdv

Poor body health is a more pronounced manifestation of mental illness than poor brain health. 🧵1/12

Ever been shocked by perfect model performance in publications using AI algorithms compared to traditional statistical methods? This is often due to "Data Leakage." Data leakage creates false relationships between variables due to errors in data collection, sampling,

First GLP-1/glucagon dual receptor drug randomized trial to block fibrosis progression and show significant improvement of MASH liver disease nejm.org/doi/full/10.10… NEJM

🙂

#AI to identify multi-organ signatures of #Fibrosis in #heart #kidney #liver and gut from #MRI, #proteomic and #genomic data. Kudos to Patrick Ellinor et al. nature.com/articles/s4159… Nassir Marrouche Christian Sohns Prash Sanders Atul Verma Elad Anter Uli Schotten Stanley Nattel

Just published NEJM Tirzepatide (GLP-1) clicks for protection vs sleep apnea in 2 randomized placebo-controlled trials: less symptoms, hypoxia, systolic BP, and reduction of inflammation by hs-CRP (w/ or w/o CPAP) nejm.org/doi/full/10.10… Atul Malhotra, MD #ADA2024

Improvement in fitness favorable for male and females with AF, however greater benefit for AF freedom in females though more regression from persistent to paroxysmal in males #AHAJournals #Epeeps doi.org/10.1161/CIRCEP…

2 new large observational studies show GLP-1 drugs are associated with reduced dementia in people with diabetes —Sweden, vs other drugs for diabetes (Figure) thelancet.com/journals/eclin… —US Medicare population, vs DPP-4 diabetesjournals.org/diabetes/artic…

GLP-1 drugs and reduction of cancer Among ~1.6 million people w/ T2 diabetes, for GLP-1 drugs vs insulin Rx, there was less risk for 11 of the 13 cancers associated with obesity jamanetwork.com/journals/jaman…

🚨 📰 Digital Footprints of #obesity Treatment: GLP-1 Receptor Agonists and the #HealthEquity Divide: Our research investigates the societal implications of access to GLP-1 agonists, particularly in light of recent clinical trials demonstrating the efficacy of Semaglutide in

Artificial intelligence detects breast cancer 5 years before it develops #MedEd #MedTwitter #SCIENCE #technology #oncology #Cancer #Diagnosis

Great advice on ? ✓ apoB (a snippet) Full video interview YouTube (link in post)

Fun fact! Sleeve gastrectomy_one of the most popular bariatric surgeries_was first performed in 1990!!!!. I wonder if this GLP-1 startup would have made it back then, how many people could have avoided that unnecessary procedure and the complications (i.e.obstruction) they’re

3 things that slow the pace of epigenetic aging, from my conversation with Prof Steve Horvath, the pioneer of these clocks —Exercise —More vegetables in diet —GLP-1 drugs In the new Ground Truths podcast (link in profile) "Have these findings changed your diet or made you exercise

Intra-individual variability in #Lipoproteina : the value of a repeat measure for reclassifying individuals at intermediate risk released at #ESCCongress and just published in #EHJOpen👉 bit.ly/3z3hHJE EHJOpen Editor-in-Chief Tarek Harb Efthymios (Timos) Ziogos Thorsten Leucker